Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Nephros, Inc. NEPH
$1.46
+$0.05 (3.55%)
На 18:01, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
14783709.00000000
-
week52high
2.44
-
week52low
0.91
-
Revenue
9975000
-
P/E TTM
-2
-
Beta
1.24117600
-
EPS
-0.41000000
-
Last Dividend
0.00000000
-
Next Earnings Date
10 мая 2023 г. в 20:00
Описание компании
Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States. The company operates in three segments: Water Filtration, Pathogen Detection, and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also develops and sells real-time water testing systems to provide actionable data on waterborne pathogens; and medical device products for patients with renal disease, including a 2nd generation hemodiafiltration system for the treatment of patients with end stage renal disease. In addition, it offers water filters that improve the taste and odor of water, as well as reduce biofilm, bacteria, and scale build-up in downstream equipment under the Nephros and AETHER brands for the food service, hospitality, convenience store, and health care markets. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| B. Riley FBR | Buy | 26 янв 2021 г. | |
| Maxim Group | Buy | 25 ноя 2020 г. | |
| Benchmark | Speculative Buy | 25 ноя 2020 г. | |
| Benchmark | Speculative Buy | 24 окт 2019 г. | |
| Maxim Group | Buy | 04 окт 2019 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Harris Joseph Michael | A | 7080 | 7080 | 05 янв 2023 г. |
| Harris Joseph Michael | A | 8402 | 8402 | 05 янв 2023 г. |
| Amron Arthur H | A | 7080 | 7080 | 05 янв 2023 г. |
| Amron Arthur H | A | 27613 | 27613 | 05 янв 2023 г. |
| Gwydir Tom | A | 7080 | 7080 | 05 янв 2023 г. |
| Gwydir Tom | A | 43226 | 27613 | 05 янв 2023 г. |
| Spandow Oliver J. | A | 7080 | 7080 | 05 янв 2023 г. |
| Spandow Oliver J. | A | 67310 | 42481 | 05 янв 2023 г. |
| Lask Alisa | A | 7080 | 7080 | 05 янв 2023 г. |
| Lask Alisa | A | 39338 | 27613 | 05 янв 2023 г. |
Новостная лента
Nephros Schedules First Quarter 2023 Financial Results Conference Call
GlobeNewsWire
26 апр 2023 г. в 07:30
SOUTH ORANGE, NJ , April 26, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its first-quarter financial results on Wednesday, May 10, 2023 after market close and will host a conference call that same day at 4:30pm ET.
Nephros, Inc. (NEPH) Q4 2022 Earnings Call Transcript
Seeking Alpha
08 мар 2023 г. в 22:28
Nephros, Inc. (NASDAQ:NEPH ) Q4 2022 Earnings Conference Call March 8, 2023 4:30 PM ET Company Participants Kirin Smith - PCG Advisory Andrew Astor - President and CEO Conference Call Participants Anthony Vendetti - Maxim Group Joseph Schuler - JAS Investors Operator Good afternoon, and welcome to the Nephros Inc. Fourth Quarter 2022 Financial Results Conference Call. [Operator Instructions] Please note, this event is being recorded.
Nephros, Inc. (NEPH) Q3 2022 Earnings Call Transcript
Seeking Alpha
06 ноя 2022 г. в 02:29
Nephros, Inc. (NASDAQ:NEPH ) Q3 2022 Earnings Conference Call November 2, 2022 4:30 PM ET Company Participants Kirin Smith - PCG Advisory Andrew Astor - President and CEO Conference Call Participants Marc Wiesenberger - B. Riley Securities Paul Resnik - Resnik Asset Management Operator Good day, everyone, and welcome to the Nephros, Inc. Third Quarter 2022 Financial Results Conference Call.
Nephros Third Quarter 2022 Financial Results Conference Call
GlobeNewsWire
19 окт 2022 г. в 07:30
SOUTH ORANGE, NJ, Oct. 19, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its third-quarter financial results on Wednesday, November 2, 2022 after market close and will host a conference call that same day at 4:30 pm ET.
Nephros to Present at LD Micro Main Event XV
Newsfile Corp
12 окт 2022 г. в 07:30
South Orange, New Jersey--(Newsfile Corp. - October 12, 2022) - Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing innovative filtration and pathogen detection solutions to healthcare and commercial markets, today announced that Andy Astor, Chief Executive Officer of Nephros has been selected to present at the LD Micro Main Event XV on Tuesday October 25, 2022 at 9:30am PT at the Luxe Sunset Boulevard Hotel in Los Angeles.